TABLE 2.
Samplea | Dilution | MFI ratio of antigen-coated beads to BSA-coated beadsb
|
|||||
---|---|---|---|---|---|---|---|
SIV | SRV | HTLV | SFV | RhCMV | HVP-2 | ||
Background | 0.34 | 0.56 | 0.11 | 0.16 | 1.46 | 0.21 | |
SIV | 1:200 | 333 ± 45 | 0 | 0 | 0 | 1 | 0 |
SRV* | 1:200 | 0 | 9 ± 2 | 0 | 1 | 0 | 0 |
STLV | 1:200 | 0 | 0 | 57 ± 3 | 0 | 0 | 0 |
SFV* | 1:200 | 0 | 1 | 0 | 44 ± 2 | 0 | 1 |
RhCMV | 1:200 | 0 | 0 | 0 | 0 | 230 ± 38 | 0 |
B virus | 1:200 | 0 | 0 | 0 | 121 ± 6 | 35 ± 4 | 196 ± 19 |
*, serum samples from M. fascicularis; all other serum samples were from M. mulatta.
Data are medians ± standard deviations. The MFI ratios do not represent quantitative antibody levels; they reflect relative signals obtained for serum sample reactions to the individual antigen-coated bead sets.